Review of the pharmaceutical industry Series 2- start the deadlock changing situation.docVIP

 PAGE \* MERGEFORMAT 8 ‘Review of the pharmaceutical industry’ Series 2: start the deadlock changing situation Part said that in 2005, China’s pharmaceutical industry as a whole is characterized by: miscalculation, out of control, failure, failure, out of favor. See the article: ‘Pharmaceutical Industry Review’ series one: miscalculated control failure failure out of favor. Then, 2006 years? China’s pharmaceutical industry and pharmaceutical companies are experiencing the ‘Eleventh Five-year’ plan the first year of expectations, the impasse after the autumn of confusion, so he began thinking the occasion of change in the situation. Beginning of the period In 2006 China’s implementation of the ‘Eleventh Five-year’ plan the first year, the pharmaceutical industry also began to the corresponding ‘Eleventh Five-year’ plan. National Development and Reform Commission in the ‘pharmaceutical industry’ Eleventh Five-Year ‘development guidance’ has been clearly mapped out for the next five years, the development of China’s pharmaceutical industry, the main directions and tasks: from a fundamental change ‘to drugs to support doctors’, the establishment of the Social Open pharmacies prescription system, accelerate the progress of medical separation; integration of various resources, to cultivate internationally competitive large-scale pharmaceutical group. In fact, in this, the State Science and Technology, Food and Drug Administration, Ministry of Health and Social Security Ministry and other ministries and commissions associated with the medical and health industries have launched a number of New Deal: From the State Council issued ‘on the development of urban community health services, guidance’ to ‘rural health service system construction and development planning’ start-up; from the 19th second price reduction to the Development and Reform Commission, Ministry of Finance, Ministry of Health of eight departments have jointly issued a ‘ on further improvement and r